Skip to main content

Table 1 Experimental design and various tretament groups used in the study

From: Phytochemical analysis and antidiabetic potential of Elaeagnus umbellata (Thunb.) in streptozotocin-induced diabetic rats: pharmacological and computational approach

Group Group Category Treatment given Route
Group I Normal control Normal saline 8 mL/kg p.o.
Group II Diabetic control STZ (50 mg/kg) i.p.
Group III Positive control Glibenclamide 0.5 mg/kg p.o
Group IV Me-Ext 100 mg/kg p.o
Group V Me-Ext 200 mg/kg p.o
Group VI Chf-Ext 100 mg/kg p.o
Group VII Chf-Ext 200 mg/kg p.o
Group VIII EtAc-Ext 100 mg/kg p.o
Group IX EtAc-Ext 200 mg/kg p.o
  1. Me-Ext Methanolic extract, Chf-Ext Chloroform extract fraction, EtAc-Ext Ethyl acetate extract fraction, STZ Streptozotocin, p.o. Per oral, i.p. Intraperitoneal